The Future of Alzheimer’s Diagnosis
What if we could detect Alzheimer’s disease before the first memory fades?
In this powerful episode of Med Tech Gurus, Dr. Maria-Magdalena Patru, MD, PhD—who leads the neurology medical team at Roche Diagnostics US—explains how early diagnosis is being radically transformed through CSF and blood-based biomarker innovations. With Alzheimer’s affecting over 7 million Americans, Dr. Patru outlines how new guidelines, improved reimbursement, and diagnostic advances are helping clinicians identify the disease earlier—when treatments can still preserve cognition.
She also shares how her personal connection to Alzheimer’s drives her mission and offers advice to innovators navigating regulatory and clinical pathways. If you're building diagnostics or working on access-to-care challenges, this is a must-listen.
https://diagnostics.roche.com/us/en/products/product-category/neurology/alzheimers-disease.html
